Linked Life Data

17508240

Source:http://linkedlifedata.com/resource/pubmed/id/17508240

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
4
pubmed:dateCreated
2007-8-16
pubmed:abstractText
We performed percutaneously radiofrequency (RF) ablation of 5 renal cell carcinomas (mean diameter 26 +/- 15 mm) with computed-tomography (CT) fluoroscopic guidance using the transhepatic route. The RF electrode was successfully advanced into all tumors. RF ablation caused one minor complication (small asymptomatic perirenal hematoma); no major complications occurred. The follow-up contrast-enhanced CT images showed no local tumor progression of any tumors in a median period of 10 months (range 3-14 months). In conclusion, it seems that this transhepatic approach is safe and can be an alternative method for electrode insertion during RF ablation of selected renal tumors.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:status
MEDLINE
pubmed:issn
0174-1551
pubmed:author
pubmed:issnType
Print
pubmed:volume
30
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
765-9
pubmed:meshHeading
pubmed:articleTitle
Transhepatic approach for percutaneous computed-tomography-guided radiofrequency ablation of renal cell carcinoma.
pubmed:affiliation
Department of Radiology, Okayama University Medical School, 2-5-1 Shikata-cho, Okayama, 700-8558, Japan. iguchi@cc.okayama-u.ac.jp
pubmed:publicationType
Journal Article, Technical Report